Johnson & Johnson MedTech
Manufacturing · Pennsylvania, United States · 75,000 Employees
View Company Info for Free
About
Headquarters
1302 Wrights Ln E, West Chester, Pennsylvania, ...Phone Number
(800) 872-3080Website
www.jnjmedtech.comRevenue
$27.1 BillionIndustry
Most Recent Scoops
Jul 17 2024
Promotion
May 1 2024
New Hire
Johnson & Johnson MedTech has announced that Duane Arsdale has joined the organization as Chief Financial Officer.
Who is Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology and a passion for people to transform the future of me dical intervention and empower everyone to live their best life possible.Read more
Johnson & Johnson MedTech Org Chart
Is Johnson & Johnson MedTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Johnson & Johnson MedTech, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Johnson & Johnson MedTech recently announced quarterly report
Funding: Get notified immidiatlly once Johnson & Johnson MedTech has new funding data
Congratulate Masked Content for being promoted to Masked Content at Johnson & Johnson MedTech
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Johnson & Johnson MedTech launches new products
Check if Johnson & Johnson MedTech has recently received funding, and reach out quickly before it becomes old news!
Click to see if Johnson & Johnson MedTech had a recent Job posting/layoffs
Check out if Johnson & Johnson MedTech is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Johnson & Johnson MedTech as Masked Content
Find 3 more new buyers
Johnson & Johnson MedTech Email Formats
Johnson & Johnson MedTech uses at least 5 email formats with first initials + last (ex. JSmith@its.jnj.com) being used 23.8% of the time
| Johnson & Johnson MedTech Email Formats | Percentage | |
|---|---|---|
| first initials + last | JSmith@its.jnj.com | 23.8% |
| first initials + last initials | JSmith@its.jnj.com | 9.5% |
| first.last | John.Smith@its.jnj.com | |
| first + last | JohnSmith@its.jnj.com | |
| first_last | John_Smith@its.jnj.com | |
Get Verified Emails
View Email Formats for Johnson & Johnson MedTech
Johnson & Johnson MedTech Employee Growth Rate
View Johnson & Johnson MedTech’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Johnson & Johnson MedTech Tech Stack
A closer look at the technologies used by Johnson & Johnson MedTech
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Most Recent Scoops
Jul 17 2024
Promotion
Executive Moves, Promotion
Jul 17 2024
Left Company
Executive Move
Executive Moves, Left Company
May 1 2024
New Hire
Johnson & Johnson MedTech has announced that Duane Arsdale has joined the organization as Chief Financial Officer.
Apr 22 2024
Event
Events
Jan 23 2024
Left Company
Executive Move
Johnson & Johnson MedTech News & Media
JOHNSON & JOHNSON MEDTECH LAUNCHES NEW PRESBYOPIA-CORRECTING INTRAOCULAR LENS TECNIS PURESEE IN EMEA
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision
Johnson & Johnson MedTech Acquires Laminar, Inc.
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson & Johnson MedTech acquired Laminar for an upfront payment of $400 million, subject to customary adjustments, with additional potential clinical and regulatory milestone payments in 2024 and beyondLeeds NHS and Johnson & Johnson MedTech develop new partnership
Leeds Teaching Hospitals NHS Trust and Johnson & Johnson MedTech have revealed a new strategic collaboration to drive forward health innovation plans in West Yorkshire.Ethicon Introduces ETHIZIA™ Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding
Addition of hemostatic patch complements Ethicon's comprehensive Biosurgery portfolio and ability to address critical unmet needs in controlling bleeding RARITAN, N.J., Nov. 15, 2023 /PRNewswire/ -- Ethicon*, a Johnson & Johnson MedTech company**, today announced the approval of ETHIZIA™,...
Read more news
Frequently Asked Questions Regarding Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible.... Read More
